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Abstract.  Site-directed  oligonucleotide mutagenesis 
has been used to introduce chain termination  codons 
into the cloned DNA sequences encoding the carboxy- 
terminal  transmembrane  (27 amino  acids) and cyto- 
plasmic  (10 amino acids) domains  of influenza  virus 
hemagglutinin  (HA).  Four mutant  genes were con- 
structed which express truncated  forms of HA that 
lack the cytoplasmic domain and terminate  at amino 
acids 9,  14,  17, or 27 of the wild-type hydrophobic 
domain.  Analysis of the biosynthesis and  intracellular 
transport  of these mutants  shows that (a) the cytoplas- 
mic tail is not needed for the efficient transport  of HA 
to the cell surface;  (b) the stop-transfer  sequences are 
located in the hydrophobic domain;  (c)  17 hydrophobic 
amino acids are sufficient to anchor  HA stably in the 
membrane;  and (d) mutant proteins  with truncated 
hydrophobic domains  show drastic  alterations  in trans- 
port,  membrane  association,  and  stability. 
LYCOPROTEINS that span the plasma membrane once 
typically contain a stretch of 20-25 consecutive un- 
charged  residues  with  considerable  hydrophobic 
character (41, 45, 50, 54), followed by a sequence of hydro- 
philic amino acids that varies both in amino acid sequence 
and  length  and  lies  on  the  cytoplasmic  side  of the  lipid 
bilayer. The functions of these two domains have been inves- 
tigated in a number of laboratories by analyzing the biosyn- 
thesis,  intracellular  transport,  and biological properties  of 
mutant and chimeric forms of a number of different integral 
membrane  proteins.  Deletion  of the  DNA  sequences  en- 
coding  the  transmembrane  and  cytoplasmic  tail  domains 
of influenza  virus hemagglutinin  (HA) t  (17, 51),  vesicular 
stomatitis virus (VSV) G protein (42), herpes simplex glyco- 
protein D (27), or a murine Class I histocompatibility anti- 
gen (64) resulted in the expression of truncated forms of the 
proteins that were secreted from eukaryotic cells. In other 
studies, deletion of the transmembrane  domain resulted in 
both loss of membrane association and an inability of the mu- 
tant  glycoprotein to be transported  from the endoplasmic 
reticulum (39, 56, 57). In a prokaryotic system, deletion of 
the transmembrane domain converted the coliphage fl gene 
III protein from an integral membrane protein to a secreted 
periplasmic  form  (9).  Membrane  association  of many  of 
these truncated  proteins  could be  restored by addition  of 
authentic transmembrane domains from other integral mem- 
brane proteins (18, 38, 44) or addition of artificial domains 
of 16 or more hydrophobic amino acids (8).  Furthermore, 
1.  Abbreviations  used  in  this paper:  endo  H,  endoglyeosidase H;  HA, 
hemagglutinin; VSV,  vesicular stomatitis virus. 
conversion of a secretory protein to a membrane-bound form 
has been achieved by fusing the transmembrane  and cyto- 
plasmic domains of VSV G protein or influenza HA to rat 
growth hormone (20, 40). Finally, expression in a ceU-free 
system of a chimeric protein consisting of the transmembrane 
anchor of an IgM heavy chain inserted between 13-1actamase 
and a-globin resulted in a transmembrane protein with the 
predicted topology (60). These results have established that 
a  major function of the carboxy-terminal hydrophobic do- 
main  is to anchor  the transmembrane  protein  in the lipid 
bilayer. Alteration or partial deletion of cytoplasmic tails (6, 
7, 12, 14, 32, 37, 57, 63, 64) does not usually affect membrane 
integration  although  the transport  of the  resulting  mutant 
proteins  through  the  secretory pathway  may be inhibited, 
probably as a consequence of protein denaturation or mal- 
folding (12,  18a). 
Correct positioning of an integral membrane protein in the 
lipid bilayer requires some form of stop-transfer signal that 
halts the co-translational  translocation of the nascent poly- 
peptide across the membrane of the rough endoplasmic re- 
ticulum  (45).  Although  the nature  of such signals has not 
been unambiguously established,  it has been proposed that 
the hydrophobic transmembrane domain and the positively 
charged amino acid that frequently marks the beginning of 
the hydrophilic cytoplasmic domain may act together to halt 
the translocation process (4, 45). Recent analyses of mem- 
brane proteins with mutated cytoplasmic domains indicate 
that positively charged residues may not play an obligatory 
role in stop-transfer  (6,  64). 
In  this  paper  we have  investigated  the  function  of the 
carboxy-terminal hydrophobic and cytoplasmic domains of 
HA by site-directed oligonucleotide mutagenesis of the DNA 
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troduced translational termination codons at four sites to 
generate mutant forms of HA that are  10,  20,  23,  and 28 
amino acids shorter than the wild-type protein. All four of 
these mutant proteins lack the entire sequences of the cyto- 
plasmic tail but retain variable quantities of the hydrophobic 
transmembrane  region.  Analysis of the  biosynthesis and 
intracellular  transport  of the  mutants  shows  that  (a)  the 
cytoplasmic domain of HA contains no signals that are essen- 
tial for movement of the protein to the cell surface; (b) the 
stop-transfer signal is located within the hydrophobic trans- 
membrane domain; (c) the entire hydrophobic region is not 
needed to anchor HA in the membrane; and (d) severe trun- 
cation of the hydrophobic domain affects the membrane as- 
sociation, stability,  and intracellular transport of HA. 
Materials and Methods 
General Recombinant DNA Techniques 
Buffers and reaction conditions for restriction enzymes, T4 DNA ligase, and 
the Kienow fragment of DNA polymerase I were those listed by the com- 
mercial source, New England Biolabs (Beverly, MA). Reverse transcriptase 
was obtained from Life Sciences Inc. (St. Petersburg, FL), and RNasin was 
obtained from Promega Biotec (Madison,  WI).  Isolation of DNA frag- 
ments, addition of restriction site linkers, preparation of  plasmid DNAs, and 
other standard recombinant DNA techniques were carded out as described 
in Maniatis et al. 00) and in other references cited therein. Transformation 
ofEscherichia coli DH-I or TG-I cells was done by the method of Hanahan 
(21). 
Construction and Cloning of  a Full-length cDNA of the 
HA from the X-M Strain of  Influenza Virus 
X-31, a recombinant influenza virus bearing the HA from the A/Aichi/68 
strain (25) was kindly supplied by John Skebel, National Institute of Medi- 
cal Research, Mill Hill, United Kingdom. Purification of virion RNAs and 
the construction and cDNA cloning of the nucleotide sequences encoding 
the ectodomain of the X-31 HA have been described previously (11). To syn- 
thesize the full-length gene, a  316-bp XhoI-BamHI restriction fragment 
(nucleotides 1,302-1,618) was isolated from the 3' end of the partial cDNA 
clone. This fragment was annealed to total Aichi virion RNAs and double- 
stranded cDNA synthesis was carded out according to published procedures 
(30). After second strand synthesis, the 3'-terminal hairpin loop was excised 
using S1 nuclease and the DNA ends were repaired using the Kienow frag- 
ment of DNA polymerase I before ligation to phosphorylated SalI linkers. 
The double-stranded DNA molecules were then cleaved with BamHI and 
Sall to yield fragments of'x,  llO bp which were inserted into the M13 cloning 
vector, mpl8 (31, 47).  Single-stranded DNAs were prepared from single 
plaque isolates and clones (mpI8-HA-TMT) containing the complete car- 
boxy-terminal coding region were identified by DNA sequence analysis 
using the chain termination technique (46). The double-stranded replicative 
form of the M13 DNA was prepared from phage containing this complete 
sequence. The ll2-bp BamHI-SalI restriction fragment encoding the trans- 
membrane and cytoplasmic domains of X-31 HA was isolated and inserted 
into an SV40 vector downstream of the sequences encoding the X-31 HA 
ectodomain to generate a full length cDNA copy of the HA gene (see below 
and Fig.  1 A). 
Site-specific Mutagenesis of  HAcDNA Using 
Mismatched Oligonucleotides 
Four 17-mer oligonucleotides that correspond except for a single mismatch 
to sequences encoding regions of the transmembrane domain and cytoplas- 
mic tail  of X-31 HA were used to generate single base substitutions that 
introduced termination codons into the HA gene (Fig.  2).  The oligonu- 
cleotides were synthesized using an Applied Biosystems 380-A DNA Syn- 
thesizer and purified by electrophoresis through 20% polyacrylamide gels 
containing 7 M  urea.  Mutagenesis was carried out by the double-primer 
method of Zoller and Smith (61, 62) using mpl8-HA-TMT as the template. 
As described in Fig. 1 B, the oligonucleotide primers were extended using 
the Klenow fragment of DNA polymerase I in the presence of T4 DNA li- 
gase. Competent TG-1 cells were transfected with an aliquot of the reaction 
mixture which contained partially and fully double-stranded DNA mole- 
cules. The resulting plaques were screened by in situ hybridization using 
the appropriate 32p-labeled mutagenic oligonucleotides as probe. Bacterio- 
phages containing mutant  sequences were plaque  purified,  and  single- 
stranded DNA was purified for use as template for sequence analysis by the 
chain termination method of Sanger et al. (46, 47). Once the desired base 
substitution had been confirmed, the double-stranded replicative form of 
each mutant phage DNA was prepared and purified by centrifugation on 
CsC12 gradients. The BamHI-SalI HA DNA fragment carrying each point 
mutation was isolated and used to  replace the equivalent wild-type se- 
quences in the SVEXHA recombinant viral genome (see below and Fig. 
1 B). 
SV40 Vectors  Designed To Express Wild-type and 
Truncated Forms  of  X-31 HA 
A vector, SVEXHA-A- (Fig.  1 A), has previously been constructed to ex- 
press the X-31 HA ectodomain (Bye, J., and M. J.  Gething, unpublished 
results). This vector closely resembles SVEHA20-A- which has been used 
to express the ectodomain of the HA from the A/Japan/305/57  strain of 
influenza virus (17). pSVEXHA-A- contains the ClaI-BamHI restriction 
fragment encoding the X-31 HA ectodomain (11) inserted between the HpaII 
(nucleotide 346) and BamHI (nucleotide 2533) sites of SV40 DNA, so that 
the HA sequences replace the late region of the SV40 genome, which en- 
codes the capsid proteins. For amplification and manipulation of the DNA 
sequences, the genome was inserted through the unique KpnI site in the 
SV40 sequence into plasmid pKSB (12). The construction of a vector that 
contains the full length copy of the wild-type X-31 HA gene is shown in 
Fig.  1 A. Plasmid pSVEXHA-A- was cleaved with amHI, and a BamHI- 
Sall-XhoII  adaptor  linker  was  inserted  into  the  BamHI  site.  The  ll2-bp 
BamHI-SalI fragment  encoding the carboxy-terminal  sequences  of HA (see 
above) was then inserted between the new BamH1 and SalI sites of the vector 
to yield pSVEXHA. For expression of the truncated,  mutant forms of HA, the 
ll2-bp BamI-II-SalI fragments containing new termination codons introduced by 
oligonucleotide-directed  mutagenesis were inserted into the pSVEXHA vector, 
replacing the wild-type fragment (see above and Fig.  1 B). Before generation 
of recombinant  virus stocks,  the pKSB plasmid sequences  were removed by 
digestion with KpnI, and the recombinant SV40-HA genome was purified by gel 
electrophoresis  and recircularized  by dilute ligation (16). 
Generation of  SV40-HA Recombinant Virus Stocks and 
Infection of CV-1 Cells 
SV40-HA recombinant genomes containing wild-type and mutant forms of 
the X-31 HA gene were transfected into CV-I cells using DEAE-dextran and 
chloroquine as previously described (12). High-titer virus stocks were de- 
veloped and used to infect fresh monolayers of CV-I cells for analysis of the 
biosynthesis and intracellular transport of wild-type and mutant HAs (16). 
Conditions for growth and infection of CV-1 cells were as described previ- 
ously (11). 
Analysis of the Biosynthesis and IntraceUular 
Processing of Wild-type and Mutant HAs 
To quantitate the amount of HA protein produced, solid-phase radioimmune 
assay of supernatants and extracts of CV-1 cells infected with SVEXHA 
recombinant viruses was carried out as described previously (11, 16) using 
a high titer rabbit antiserum directed against X-31 HA. Analysis of the bio- 
synthesis of wild-type and mutant HA proteins was carried out by pulse- 
chase radiolabeling of infected cells with [JSS]methionine followed by immu- 
noprecipitation  and SDS PAGE (17). Digestion with endoglycosidase  H (endo 
H) was carried out as described by Owen et al.  (35).  Binding of red cells to 
hemagglutinin expressed on the surface of infected CV-1 cells was performed as 
described previously (16). The location of wild-type and mutant forms of HA 
was determined by indirect  immunofluorescence  of infected cells (12). 
Phase Partitioning of Wild-type and Mutant HAs in 
Triton X-114 Solutions 
36 h  after infection with SVEXHA recombinant viruses, monolayers of 
CV-1 cells were washed with ice cold Tris-buffered saline and then extracted 
on ice in 10 mM Tris-HCI, pH 7.5,  150 mM NaC1,  containing 1% Triton 
X-114. After removal of nuclei and cell debris by brief centrifugation, the 
cell extract was separated into detergent and aqueous (pellet and superna- 
tent) phases as described by Bordier (5).  The detergent phase was recon- 
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Figure 1. Mutagenesis and ex- 
pression of X-31 HA. (.4) Con- 
struction of an SV40-based re- 
combinant vector (SVEXHA) 
to express a full-length copy 
of the cDNA encoding X-31 
HA.  (B)  Oligonucleotide- 
directed  mutagenesis  of  se- 
quences  encoding  the  trans- 
membrane  and  cytoplasmic 
domains of X-31 HA and con- 
struction of SVEXHA-TM re- 
combinant vectors to express 
truncated HA  proteins.  De- 
tails  of the  procedures used 
are described in Materials and 
Methods. 
stituted to the same volume as the aqueous  phase by addition of 10 mM 
Tris-HCl, pH 7.4, 150 mM NaCI, and equal  aliquots of the two phases were 
immunoprecipitated using anti-X31 HA antiserum. The amount of HA pro- 
tein in each phase was visualized by separation of the immunoprecipitated 
proteins by SDS PAGE  and autoradiography. 
Results 
Construction and Expression of  Mutant Genes 
Coding  for HAs with Altered Transmembrane and 
Cytoplasmic Domains 
Site-directed  oligonucleotide  mutagenesis  was  used  to  in- 
traduce chain termination  codons at  four  sites  within the 
DNA sequences coding for the transmembrane and cytoplas- 
mic tail regions of the HA from the X-31  strain of influenza 
virus (see Materials and Methods and Fig.  1). The locations 
of these mutations are shown in Fig. 2. In mutant HA-TM27, 
UGA  replaces  the  AGA  triplet  (Arg)  at  codon  27  of the 
hydrophobic transmembrane sequence, resulting in the syn- 
thesis of a truncated protein that terminates exactly at the end 
of the transmembrane region and lacks all sequences of the 
hydrophilic  cytoplasmic  tail.  In  mutants  HA-TM17,  HA- 
TM14,  and  HA-TM9,  termination  codons  have been  sub- 
stituted  for  UUG  (Leu),  UGU  (Cys),  and  UCA  (Ser)  at 
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coding strand  ......  TGG ATC CTG TGG ATT TCC TTT 
non-coding  strand  ......  ACC TAG GAC ACC TAA AGG AAA 
Ala lle Ser Cys Phe Leu Leu Cys Val Val Leu Leu Gly Phe  lle Met 
GCC ATA TCA TGC TTT TTG CTT TGT GTT GTT TTG CTG GGG TTC ATC ATG 
CGG TAT AGT ACG AAA AAC GAA ACA CAA CAA AAC GAC CCC AAG TAG TAC 
-  (tJm14)CTT  TG~  GTT  GTT  TTG  CT 
(tmg)c  ATA  TGA  TGC  TTT  TTG  C  (tm17)T  GTT TAG  CTG  GGG  TTC  A 
Trp Ala Cys Gln Arg Gly Asn lle Arg Cys Asn  lle Cys lle  STOP 
TGG GCC TGC CAG AGA GGC AAC ATT AGG TGC AAC AAT TGC ATT TGA 
ACC CGG ACG GTC TCT CCG TTG TAA TCC ACG TTG TTA ACG TAA ACT 
(tm27)GC  CAG  TGA  GGC  AAC  ATT 
Figure 2. Oligonucleotide-di- 
rected mutagenesis  of sequences 
encoding the transmembrane 
and  cytoplasmic domains  of 
X-31 HA. The nucleotide se- 
quence of the DNA encoding 
the transmembrane and cyto- 
plasmic domains of X-31 HA 
is  shown together  with  the 
mismatched  17-mer oligonu- 
cleotides  used  to  introduce 
termination codons within the 
membrane-spanning region. 
amino acid positions 17,  14, and 9, respectively, within the 
hydrophobic sequence. These mutants express forms of HA 
that lack both the cytoplasmic tail and progressively increas- 
ing portions of the hydrophobic domain (Fig. 3). 
SV40-HA recombinant genomes were constructed in which 
either the wild-type HA gene (XHA) or the mutant genes 
(HA-TM27,  HA-TM17, HA-TM14,  and HA-TM9) were used 
to replace the coding sequences of the late region of SV40 
DNA (see Materials and Methods and Fig. 1). These recom- 
binant genomes were transfected into simian CV-1 cells and 
high titer recombinant virus stocks were developed as de- 
scribed previously (12, 16). Monolayers of CV-1 cells were 
infected with these virus stocks and the amount of HA pres- 
ent in supernatants and cell extracts was measured by solid- 
phase radioimmune assay.  After 60 h,  cells infected with 
SVEXHA, SVHA-TM27,  and SVHA-TM17 contained levels 
of X-31 HA similar to those obtained in this expression sys- 
tem for the HA of  the Japan strain of  influenza virus (16), i.e., 
'~10  s molecules of HA per cell. By contrast, CV-1 cells in- 
fected with SVHA-TM14 and SVHA-TM9 contained '~5-10- 
fold fewer HA molecules per cell. Data presented below (see 
Fig. 5) show that although the wild-type HA and all four mu- 
tants were synthesized at approximately the same rate, the 
HAs of TM-14 and TM-9 were less stable than those of wild- 
type, TM-27, or TM-17. Thus less HA accumulated during 
the course of infection of CV-1 cells with these mutants; it 
is this accumulation of the protein that is measured by the 
radioimmune assay. In no case was any HA antigen detected 
in the medium of infected cells indicating that truncation of 
the hydrophobic anchor of HA to a length as short as nine 
hydrophobic amino acids did not result in secretion of the 
protein from the cell. 
Cellular Localization of Truncated Forms of  HA 
Indirect immunofluorescence and hemagglutination assays 
were used to determine the cellular location of truncated 
forms of HA in infected CV-1 cells. Fig. 4 shows examples 
of the results obtained when cells infected for 42 h with the 
various recombinant viruses were assayed for erythrocyte 
binding  or  were permeabilized and  stained  with  an  HA- 
specific antisera to reveal both intracellular and cell surface 
forms of the wild-type and truncated HAs.  Cells infected 
with  SVHA-TM27 displayed patterns  of hemagglutination 
and  immunofluorescent labeling  that  were  indistinguish- 
able from those seen in CV-1 cells infected with the wild- 
type SVEXHA recombinant vector. Guinea pig erythrocytes 
bound densely to >90-95 % of the cells expressing X-31 HA 
or HA-TM27. In addition to diffuse fluorescent labeling of  the 
cell surface, there was strong staining of the perinuclear re- 
gion as well as reticular staining of the cytoplasm- a pattern 
that is typical of glycoproteins synthesized in the endoplas- 
mic reticulum and transported to the cell surface via the 
Golgi apparatus (12, 16,  17). 
By contrast, only 5-10%  of the cells expressing mutant 
HA-TM17 bound erythrocytes or displayed any surface fluo- 
rescence.  These  results  were  obtained  consistently,  even 
though >95 % of the cells were shown to be infected by using 
for  immunofluorescence  an  antiserum  which  recognizes 
SV40 T-antigen. At late times (60-72 h) in the infection, the 
proportion of cells expressing detectable amounts of surface 
HA increased to a maximum of 15-20% of the total popula- 
tion.  Those cells that showed no surface fluorescence dis- 
played very strong staining of the endoplasmic reticulum. In 
some  cells,  there also  appeared  to be a  concentration of 
fluorescence in  the juxtanuclear  region,  which  might  be 
taken as evidence that the HA proteins were also located 
within the Golgi stacks. However, similar patterns of staining 
were  seen in  control experiments in  which  infected CV-1 
cells were stained with an antiserum (29) that reacts spe- 
cifically with antigens localized only in the endoplasmic re- 
ticulum. Furthermore, Poruchynsky et al. (36) have shown 
that in COS-7  cells (19),  which are derived from the CV-1 
cells used in this study, the Golgi stacks in the juxtanuclear 
region are spatially intertwined with an extensive endoplas- 
mic reticulum, so that in this region bright but not totally 
coincident immunofluorescence is obtained with probes for 
either endoplasmic reticulum or Golgi elements.  The im- 
munofluorescent staining  pattern  of cells  expressing HA- 
TM17, taken together with the results of the analysis of the 
biosynthesis of this molecule (see below), suggest that the 
transport of HA-TM17 along the exocytotic pathway is de- 
fective. In most cells of the infected population the mutant 
protein did not progress through the Golgi apparatus; how- 
ever in a small proportion of cells, the protein reached the 
plasma membrane at a concentration sufficient for its display 
in a biologically active form. The cause of this heterogeneity 
is unknown, but it has been observed previously in cells ex- 
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Figure 3.  Comparison of the 
carboxyl-terminal  sequences 
of the wild-type and truncated 
X-31 HA proteins. 
pressing another mutant of HA (HA164) that is blocked at 
a later, post-Golgi stage in the exocytotic pathway (12). 
Cells expressing HA-TM14 and HA-TM9 were unable to 
bind erythrocytes at any stage during the infectious cycle. 
The infected cells displayed a pattern of immunofluorescent 
staining consistent with localization of the mutant proteins 
solely in the endoplasmic reticulum. Furthermore, the stain- 
ing  pattern  seen  in  cells  infected  with  SVHA-TM14  or 
SVHA-TM9 was identical to that seen in cells expressing an- 
other mutant of HA (HAxpBR) which has been shown pre- 
viously to be restricted to the endoplasmic reticulum (12). 
These data suggest that HA-TM14 and HA-TM9 are blocked 
at an early stage in the transport pathway and are unable to 
move to the Golgi complex. Striking differences are apparent 
between the pattern of fluorescence displayed by cells in- 
fected by HA-TM17 or by HA-TM14 or HA-TM9 (Fig. 4) even 
though the biochemical data indicate that all three mutant 
proteins are transported inefficiently to the Golgi complex. 
The reticular pattern of HA-TM17 is much more extensive, 
reaching almost to the periphery of the cell. By contrast, 
HA-TM14 and HA-TM9 molecules appear to be localized 
closer to the nucleus. It remains to be established whether 
this apparent difference in intracellular localization is merely 
a consequence of the presence of greater numbers of HA- 
TM17 molecules in the endoplasmic reticulum, or whether 
this protein progresses further than HA-TM14 or HA-TM9 
along the exocytotic pathway, for example to the smooth en- 
doplasmic reticulum or to a pre-Golgi reticulum such as that 
described by Saraste and Kuismanen (48). 
Biochemical Analysis of  the Transport of 
Truncated Forms of  HA 
The synthesis and processing of the mutant glycoproteins 
was  examined by immunoprecipitation of lysates of CV-1 
cells  that  had  been  infected  for  42  h  with  the  various 
SVEXHA vectors and then pulse-labeled with [35S]methio- 
nine. In all cases, when cells infected with the mutant viruses 
were pulse-labeled for 10 min, the immunoprecipitated HA 
polypeptides  migrated  through  SDS  polyacrylamide gels 
with an apparent molecular mass of ~74-76 kD (Fig. 5). The 
molecular mass of the nonglycosylated forms of both wild- 
type and mutant HAs  synthesized in  tunicamycin-treated 
cells is ,,o63 kD (data not shown). Thus, all of the mutant 
proteins acquired core oligosaccharide units in the endoplas- 
mic reticulum. 
Trimming of mannose-rich core oligosaccharides begins 
in the endoplasmic reticulum and is completed after the gly- 
coprotein arrives in the medial portion of  the Golgi apparatus 
(26).  Mannose-rich core oligosaccharides can be removed 
from the polypeptide(s) in vitro by digestion with endo H 
(53),  while completely trimmed core oligosaccharides are 
resistant to the enzyme. Thus, acquisition of resistance to 
endo H  is a reliable measure of transport of glycoproteins 
from the endoplasmic reticulum to the medial Golgi ap- 
paratus. To determine how truncation of the transmembrane 
domain of the  HA  might affect its  transport,  CV-1 cells 
infected with recombinant viruses were pulse-labeled with 
[35S]methionine for 10 min and incubated in the presence of 
an excess of  nonradioactive methionine for periods up to 8 h. 
Aliquots of the immunoprecipitated HAs were treated with 
endo H and analyzed by SDS PAGE. The results of these ex- 
periments are shown in Fig. 5. The wild-type X-31 HA and 
HA-TM27  molecules  synthesized in  the  10-min  labeling 
period became largely resistant to the enzyme during a 30- 
min chase and maximally resistant during 1 h of chase. 3[-31 
HA has  seven potential glycosylation sites  and complete 
removal of  core oligosaccharides from these sites reduces the 
molecular mass of the protein by ~8,000 D (see Fig. 5). If 
all  the  core  oligosaccharides  were  completely  trimmed, 
digestion with endo H should have no effect on the molecular 
mass of the protein. However, even after extended periods of 
chase when the wild-type or TM-27 HAs had gained maxi- 
mal resistance to endo H, digestion with the enzyme reduced 
their molecular mass by *2,500 D. This is a consequence 
of  the mature X-31 HA bearing both simple and complex gly- 
cans: normally only 5 of the 7 core oligosaccharides origi- 
nally added to the protein in the endoplasmic reticulum are 
trimmed and processed-the oligosaccharides added at the 
two other sites always remain sensitive to digestion with endo 
H even after the protein has passed completely through the 
Golgi  apparatus  (33).  Analysis  of the  three-dimensional 
structure of X-31 HA has shown that these carbohydrate side- 
chains are located in clefts of the molecule, where they are 
probably shielded from trimming and processing enzymes 
(58). 
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type and truncated X-31 HAs expressed  in CV-1 
cells. 42 h after infection with SVEXHA or 
SVEXHA-TM vectors,  CV-1 cells  were as- 
sayed for localization of HA by indirect im- 
munofluorescence  using  specific  anti-X31 
HA serum (top) or for surface expression of 
HA  by  hemagglutination  of  guinea  pig 
erythrocytes (bottom). 
The acquisition of resistance to endo H by HA-TM17 was 
significantly delayed in comparison to the wild-type protein. 
Endo H-resistant material was detectable only after 4  h of 
chase, and only when the autoradiogram was exposed for a 
very long period of time (such an exposure is shown in Fig. 
6). Thus, only a small amount of newly synthesized glyco- 
protein (<5 % of the 35S-labeled protein) became terminally 
glycosylated (indicated by arrows in Fig. 5). These data are 
consistent with the results obtained from immunofluorescent 
analysis of  infected cells: the transport of the majority of HA- 
TM17 molecules between the endoplasmic reticulum and the 
medial  Golgi  is  blocked  or  severely delayed.  The  small 
proportion of radiolabeled HA-TM17 that became resistant to 
endo H is probably the source of the material detected by im- 
munofluorescence on the plasma membrane of 5-10% of the 
infected cell population. This material had a slightly higher 
molecular mass than mature X-31 HA or HA-TM27 and no 
reduction in its size occurred after digestion with endo H. 
It therefore appears that all seven of the oligosaccharides on 
a small fraction of HA-TM17 molecules became terminally 
glycosylated. A possible explanation for this finding would 
be that HA-TM17  folds much more slowly than wild-type 
X-31 HA thereby allowing the two mannose-rich oligosac- 
charides that normally are shielded to remain exposed long 
enough for them to be completely processed. 
When cells infected with SVHA-TM14  and SVHA-TM9 
were  pulse-labeled  with  [35S]methionine  and  then  incu- 
bated  with  an  excess  of nonradioactive  methionine,  the 
amounts of immunoprecipitable HA decreased with increas- 
ing length of chase. Pulse-labeled HA-TM14 protein began 
to disappear after 6-8 h of chase (data not shown), while ra- 
diolabeled HA-TM9 was completely absent from extracts of 
infected cells after 2 h of chase (see Fig. 5). Both forms of 
HA remained completely sensitive to digestion with endo H 
for as long as they were detectable. These results are consis- 
tent with the observation (Fig.  4) that HA-TM14 and HA- 
TM9 were not transported beyond the endoplasmic reticu- 
lum or a pre-Golgi compartment in the exocytotic pathway. 
Furthermore, their relative instability accounts for the com- 
paratively small amounts of these truncated forms of HA that 
accumulated during the course of infection of CV-1 cells. 
To measure the efficiency  with which the various truncated 
forms of HA reached the cell surface, infected cells were 
pulse-labeled with [35S]methionine  and then incubated for 
different lengths of  time in serum-free medium containing an 
excess of nonradioactive methionine. For the last 15 min of 
the chase period, trypsin was added to the medium at a con- 
centration (5  gg/ml) sufficient to cleave any HA at the cell 
surface into its component HA1 and HA2 subunits (15). The 
radiolabeled proteins were immunoprecipitated from cell ex- 
tracts with anti-HA serum and separated by SDS PAGE. In 
agreement with previously published data (12, 17, 44), all of 
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ogenously added trypsin within 2 h of chase (Fig. 6). HA- 
TM27 reached the cell surface with kinetics that were indis- 
tinguishable from those of the wild-type protein (results not 
shown).  However, only a  small proportion of radiolabeled 
HA-TM17 became accessible to cleavage by trypsin ("~5 % 
after 4 h of chase and ,x,10  % after 6 h [see Fig. 6]). Compari- 
son of the rate at which HA-TM17 became resistant to endo 
H with its course of appearance at the cell surface indicates 
that the delay in transport of the truncated protein occurs pri- 
marily between the endoplasmic reticulum and the Golgi ap- 
paratus. Even though the rate of transport of HA-TM17 was 
very slow, the protein gradually accumulated on the cell sur- 
face during the course of infection, eventually in some cells 
attaining a level sufficient for hemadsorption and for detec- 
tion by immunofluorescence (Fig. 4). The molecules of HA- 
TM17 which reached the plasma membrane were biologi- 
cally active and showed no sign of instability. 
By contrast, HA-TMI4 or HA-TM9 in intact cells always 
remained resistant to trypsin added in the extracellular me- 
dium (results not shown). This result is consistent with our 
inability to detect these proteins at the cell surface by the 
other assays described above. As seen previously, diminish- 
ing amounts of radiolabeled mutant proteins were immuno- 
precipitated from extracts of infected cells as the length of 
the chase was increased. We conclude that extensive trunca- 
tion of  the transmembrane domain severely compromises the 
ability of HA  to  travel  along  the exocytotic pathway  and 
renders it susceptible to proteolytic destruction. 
Triton X-114 Partitioning of the Truncated Forms of  HA 
The partitioning of proteins between an aqueous phase and 
Triton X-114 is used as a measure of their surface hydropho- 
bicity and in particular as a reflection of the interaction of 
membrane proteins with the lipid bilayer (3, 5). To determine 
whether removal of the cytoplasmic tail and truncation of the 
transmembrane anchor of  X-31 HA altered the detergent par- 
titioning of the protein, an analysis of the partitioning of the 
wild-type and trtmcated forms of X-31 HA into TX-114 was 
performed.  CV-1 cells infected for 42  h  with the various 
SVEXHA recombinant vectors were pulse-labeled for  10 
min  with  [35S]methionine  or  pulse-labeled  and  then  in- 
cubated for a further 60 rain in the presence of nonradioac- 
tive methionine before extraction with buffer containing 1% 
TX-114. The cell extracts were then partitioned as described 
in Materials and Methods, and the aqueous supernatant and 
detergent pellet fractions were immunoprecipitated and ana- 
lyzed by SDS PAGE. The results shown in Fig. 7 show that 
newly synthesized wild-type X-31 HA was distributed ap- 
proximately  equally  between  the  aqueous  and  detergent 
phases; however, partitioning into the TX-U4 phase became 
Doyle et al.  Carboxy-terminal Deletions of Influenza Hemagglutinin  1199 Figure 5. SDS PAGE of X-31 HA and mutant HA-TM proteins. CV-1 cells infected for 42 h with either SVEXHA or SVEXHA-TM recom- 
binant virus stocks were labeled for 10 min with [35S]methionine and then incubated in medium containing an excess of nonradioactive 
methionine for the times shown. Cell extracts were prepared,  and proteins were immunoprecipitated with anti-HA serum.  Aliquots of 
the precipitated proteins were treated in the presence or absence of endo H and then separated by SDS PAGE and autoradiographed. Below 
the panel showing the results for mutant TM17 is a darker exposure of a portion of  the same autoradiogram, with arrows indicating processed 
material. 
almost complete during the chase period.  In other studies 
(18a),  we have correlated the time course of partitioning of 
HA into TX-114 (and the stable integration of the protein in 
the lipid bilayer) with the time course of folding and trimeri- 
zation of the HA molecule. 
By contrast, the anchor-minus form of the protein, which 
lacked all of the hydrophobic amino acids of the transmem- 
brane region, always remained in the aqueous phase.  This 
was the case for both the core and terminally glycosylated 
forms of the protein located within the cell, and for the termi- 
nally glycosylated protein that after a  1-h chase period had 
been secreted into the medium above the cells. The partition- 
ing of HA-TM27 into the detergent phase was similar to that 
seen with wild-type HA. However, a slightly higher propor- 
tion of the HA-TM27 molecules were found in the aqueous 
supernatant indicating  that removal of the cytoplasmic tail 
had slightly decreased the interaction of the protein with TX- 
114. Inspection of the results obtained with HA-TM17,  HA- 
TM14, and HA-TM9 revealed that progressive truncation of 
the transmembrane domain further decreased the ability of 
the mutant proteins to interact with the detergent. Neverthe- 
less, >50%  of the HA-TM17 or HA-TM14 molecules parti- 
tioned into TX-114 suggesting that these truncated molecules 
still interact significantly with the detergent, and by analogy, 
with the lipid bilayer. Truncation of the transmembrane do- 
main to 9 amino acids resulted in the partitioning of the great 
majority of the HA-TM9 molecules into the aqueous phase. 
However, the small but significant proportion of the mutant 
found in the detergent phase (compared to the total absence 
of the  X-31  HA-A- in  this  phase)  suggests  that  HA-TM9 
may still interact weakly with the lipid bilayer. 
Discussion 
We have analyzed the biosynthesis and intracellular transport 
of a series of mutants of influenza virus hemagglutinin that 
express truncated forms of the protein. The mutants code for 
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wild-type X-31 HA and HA- 
TM17 expressed at the cell sur- 
face.  (A)  CV-1 cells infected 
for  42  h  with  SVEXHA or 
SVEXHA-TM17 recombinant 
viruses  were labeled for  10 
min with [35Slmethionine and 
then ircut,a   in mecUum con- 
taining an excess of nonradio- 
active mc~onine  for the times 
shown. During the last 15 rain 
of the  chase  period,  trypsin 
(5 I.tg/ml) was  added to  the 
medium above the monolayer. 
Cell extracts were then pre- 
pared, and proteins were im- 
munoprecipitated  with anti- 
HA serum, separated by SDS 
PAGE, and autoradiographed. 
(B)  Longer  exposure of the 
same autoradiogram showing 
the small amount of HA2 that 
is generated by tryptic cleav- 
age  of HA-TM17 at  the  cell 
surface. 
HAs that lack the short carboxy-terminal hydrophilic tail but 
retain some (HA-TM9, oTM14, and oTM17) or all (HA-TM27) 
of the hydrophobic amino acids that normally anchor the 
protein in the lipid bilayer.  A summary of the properties of 
the mutants is shown in Table I. These results suggest the fol- 
lowing conclusions. 
(a) The cytoplasmic tail is not needed for the efficient trans- 
port of HA to the cell surface.  HA-TM27 retains an intact 
membrane-spanning domain of 27 hydrophobic amino acids 
but contains none of the hydrophilic amino acids that form 
the cytoplasmic tail of HA. Because the intracellular trans- 
port, stability,  and biological properties of HA-TM27 are in- 
distinguishable  from those of wild-type HA, we conclude 
that  the  cytoplasmic tail  contains  no  signals  essential  for 
transport of the protein along the  exocytotic pathway.  Al- 
though HA-TM27 is a  mutant of the X-31 (Aichi) strain of 
influenza virus,  similar  results  have been obtained with a 
corresponding tail-minus  mutant  of the  HA of the  Japan 
strain of the virus (our unpublished results). We have previ- 
ously shown that some but not all alterations to the cytoplas- 
mic tail of the Japan HA affect the efficiency with which the 
protein is transported to the cell surface (12). These results 
could be best explained in terms of malfolding of the affected 
molecules: deleterious alterations to the cytoplasmic domain 
were postulated to destabilize the trimeric hemagglutinin or 
to delay or prevent its assembly. Molecules with such struc- 
tural defects might be expected not to travel to the cell surface 
Figure  7.  Triton X-114 partitioning  of wild-type  and  truncated 
X-31 HA proteins. CV-1 cells infected for 42 h with SVEXHA, 
SVEXHA-A-, or SVEXHA-TM recombinant virus  stocks were 
labeled for 10 min with [35S]methionine and then incubated in me- 
dium containing an excess of nonradioactive methionine for 1 h. 
Cell extracts were prepared in buffer containing 1% Triton X-114, 
and the extracts (or the medium collected from above the cells in- 
fected with SVEXHA-A-) were partitioned as described in Materi- 
als and Methods. Equal aliquots of the detergent pellet (P) and 
aqueous supematant  (S)  phases were immunoprecipitated with 
anti-HA serum. Aliquots of the precipitated proteins were then 
separated by SDS PAGE and autoradiographed. 
Table I. Summary of  the Intracellular  Transport of 
Wild-type and Truncated HA Proteins 
Translocation  Transport  Intracellular 
to ER*  to Golgi  location 
HA-X31-WT  +  30 min 
HA-TM27  +  30 min 
HA-TM17  +  6-8 h (5-10%) 
HA-TM 14  + 
HA-TM9  + 
100% surface 
100% surface 
~20%  surface 
,x,80% ER, Golgi 
ER 
ER 
Lysosome? 
* ER,  endoplasmic reticulum. 
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add strength to this hypothesis since they eliminate the possi- 
bility that the tail plays an active role in transport of HA 
along the exocytotic pathway.  Furthermore, the hypothesis 
can easily accommodate the  observation that  HA  is  less 
tolerant of alterations to the cytoplasmic tail than of its com- 
plete removal. We have recently shown (18a) that a mutant 
HA (HAxpBR; reference 12) which has an extended cyto- 
plasmic tail, and whose intracellular transport is blocked in 
the endoplasmic reticulum, is malfolded and does not form 
the correct trimeric structure (55) of wild-type HA. 
The effects of alterations to the cytoplasmic tails of several 
other transmembrane proteins have recently been analyzed. 
Zuniga et al. (64) have shown that removal of the tail from 
the murine histocompatibility antigen H2 did not necessarily 
prevent expression of the protein on the surface of cells. 
Similar results have been obtained with mutants of Semliki 
Forest virus E2 protein (6, 14). Furthermore, a natural vari- 
ant of the low density lipoprotein receptor has been isolated 
that lacks all but 2 of the 50-amino acid cytoplasmic tail of 
the molecule (28). While this molecule is unable to undergo 
endocytosis, it is transported efficiently to the plasma mem- 
brane although at half the rate of  the wild-type molecule. The 
conclusion drawn  from these  studies  is that although the 
cytoplasmic tails of integral membrane proteins may be in- 
volved in endocytosis (28, 44), they play no essential role in 
exocytosis. A different view has been expressed by Rose and 
his co-workers, who have shown that mutation or substitu- 
tion of the cytoplasmic tail of VSV G protein can prevent or 
retard the transport of the protein along the exocytotic path- 
way (37, 43). They have proposed that the cytoplasmic tail 
of G  protein carries  a  positive signal  which  controls the 
movement of the molecule to the cell surface. However, an 
alternative explanation would be that alteration of the cyto- 
plasmic tail could affect the transport of G protein by affect- 
ing its structure. Analysis of the transport of a mutant which 
lacks all sequences of the cytoplasmic tail without any addi- 
tional foreign residues might resolve this issue. 
(b) The %top-transfer" sequences are probably entirely 
contained within the hydrophobic transmembrane domain of 
HA. The cytoplasmic tails of most transmembrane proteins 
contain one or more positively charged amino acids and it 
has been proposed that such amino acids, acting in conjunc- 
tion with the adjacent hydrophobic domain, may prevent fur- 
ther translocation of  the polypeptide across the membrane of 
the rough endoplasmic reticulum (45).  The fact that com- 
plete removal of  the cytoplasmic tail of either HA or H-2 (64) 
or removal of the basic residues from the tail of SFV E2 (6) 
or from coliphage fl gene HI protein (9) does not convert 
these integral membrane proteins into secretory molecules 
argues that the charged amino acids are not essential compo- 
nents of the stop-transfer signal.  However, removal of the 
cytoplasmic tail and all but the first two amino acids of the 
transmembrane domain did result in secretion of the trun- 
cated X-31 HA-A- molecule from the cell (see Figs.  3 and 
7). It is likely therefore that the hydrophobicity of the trans- 
membrane domain is both necessary and sufficient to prevent 
complete translocation of integral membrane proteins. 
(c) 17 hydrophobic amino acids are sufficient to anchor HA 
in  the  lipid bilayer.  Those molecules of HA-TM17  which 
reach the cell surface are not secreted but appear to be stably 
inserted in the plasma membrane, as monitored by binding 
of erythrocytes to the small proportion of the protein that 
reaches the cell surface. The size of hydrophobic transmem- 
brane domains has been thought to be constrained to a mini- 
mum of 20 amino acids by the need to span in an a-helical 
conformation the 3-nm width of the hydrophobic core of the 
lipid bilayer (10, 13, 23, 34, 52). However, that the minimum 
size for a functional hydrophobic anchor is smaller than 20 
residues is suggested by the observation of a  17-amino acid 
uncharged segment in the putative transmembrane domain of 
the T cell receptor 13-subunit (22, 59). Furthermore, Davis 
and Model (8) and Davis et al. (9) have shown firstly that a 
mutant of the fl gene III protein having a hydrophobic core 
of only 17 residues shows no impairment of anchor function 
and secondly that artificial domains of 16 or more hydropho- 
bic amino acids function to anchor the gene 1II protein in the 
lipid bilayer. Adams and Rose (2) showed that VSV G pro- 
teins with truncated hydrophobic domains that are even short- 
er retain their transmembrane orientation. However, a possi- 
bility  exists  in  these  cases  to  bury  an  additional  short 
hydrophobic stretch from the cytoplasmic domain into the 
lipid bilayer. Whether these shorter transmembrane domains 
do in fact cross the membrane in some form of helix remains 
to be determined. 
(d) Severe truncation of the hydrophobic anchor results in 
HAs that are unstable and transported inefficiently along the 
exocytotic pathway. Truncation of the hydrophobic anchor to 
9 (HA-TM9) or 14 (HA-TM14)  amino acids results in HAs 
whose transport appear to be blocked in the endoplasmic 
reticulum or in a pre-Golgi compartment. This phenotype is 
similar to that of mutants of VSV G protein in which the cen- 
tral region of the hydrophobic anchor has been either deleted 
(2) or disrupted by the insertion of a charged amino acid (1). 
Why truncation of the anchor should affect transport of these 
proteins is unknown, although once again structural defor- 
mity of the molecule, or, in the case of HA, an inability to 
form stable trimers, would seem to be likely explanations. 
Both HA-TM14 and HA-TM9 are considerably less stable 
than wild-type HA and other mutants of HA that are blocked 
in the endoplasmic reticulum (12). HA-TM9 is particularly 
sensitive to degradation and disappears from the cell within 
2 h of synthesis. That the instability and lack of transport of 
these mutant HAs are not simply due to the extent of trunca- 
tion is demonstrated by the expression and secretion from 
cells of stable ectodomain forms of X-31 HA (Fig. 7) or Ja- 
pan HA (17) that lack their entire transmembrane domains 
and cytoplasmic tails. The mechanisms by which defective 
membrane-associated proteins are identified and eliminated 
are not known. There is evidence in other systems for the 
rapid turnover of cytoplasmic proteins-particularly those 
which  are badly folded (e.g.,  proteins  synthesized in  the 
presence of amino  acid  analogues)  (24).  Lysosomal and 
nonlysosomal  mechanisms,  including  the  ATP-dependent 
ubiquitin-mediated pathway,  have been implicated in these 
processes. However, there is as yet no evidence for a similar 
system to scavenge defective membrane or secretory proteins 
that are trapped in the exocytotic pathway.  Although the in- 
tracellular site at which HA-TM9 and -TM14 are degraded is 
unknown, two lines of circumstantial evidence indicate that 
lysosomes are not involved. First, the core oligosaccharide 
groups of HA-TM9 and -14 show no evidence of  the trimming 
and processing reactions that would be expected to occur as 
the proteins pass through the Golgi apparatus on the way to 
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HA-TM9 in the presence of chloroquine (a lysosomotropic 
agent that raises the pH of lysosomes and thereby blocks pro- 
teolysis in those organelles [49]) does not inhibit degradation 
of the protein. 
Our current  working hypothesis is that the fate of mem- 
brane proteins is determined by events occurring during or 
soon after the nascent polypeptides are translocated to the lu- 
menal face of the rough endoplasmic reticulum. If the pro- 
tein can fold correctly,  it will move from the endoplasmic 
reticulum  and  travel  along  the  exocytotic  pathway  to  the 
Golgi apparatus.  If it is malfolded, the protein may become 
permanently trapped in the endoplasmic reticulum or it may 
be transported  more slowly than usual along the pathway. In 
the  most extreme  case,  presumably  when its  structure  is 
grossly deranged,  the protein is degraded.  The results de- 
scribed in this paper are consistent with the likelihood that 
alterations  in the transmembrane  domain of HA can inhibit 
the correct folding of the molecule, possibly by interfering 
with the stacking of the subunits to form the HA trimer. We 
have  recently analyzed  the folding pathways  of both wild- 
type and mutant  forms of HA and have  obtained evidence 
supporting this hypothesis that correct folding and trimeriza- 
tion is a prerequisite for intracellular  transport  (18a).  Our 
future work will be directed towards investigating  the mech- 
anisms by which mammalian cells monitor whether mem- 
brane proteins are correctly folded. The best hope of finding 
an answer to this question seems to lie in analyzing the prop- 
erties and functions of cellular proteins resident in the en- 
doplasmic reticulum that interact with nascent secretory and 
membrane proteins. 
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